Upper Back
Pain }

Pathology

Tension-type headache (TTH) is characterized by a bilateral, pressing, tightening pain of mild to moderate intensity, and is the most featureless of the primary headaches.

TTH can occur in short episodes of variable duration (episodic forms) or continuously (chronic form). Infrequent Episodic TTH (< 1 day of headache per month) usually does not require any medical treatment other than simple analgesics.

In contrast, both patients with Frequent Episodic TTH (ETTH; between 12 and 180 days of headache per year) and Chronic TTH (CTTH; at least 189 days of headache per year) may encounter considerable disability and warrant specific intervention.

The lifetime prevalence of TTH is approximately 78%, with 24% to 37% of patients suffering from TTH several times a month, 10% weekly and 2% to 3% of the population suffering from CTTH which usually lasts for the greater part of a lifetime.

Because many secondary headaches may mimic TTH, a diagnosis of TTH requires the exclusion of other organic diseases. In most patients, TTH develops from the episodic form to the chronic form, and prolonged peripheral nociceptive stimuli from pericranial myofascial tissues seem to be responsible for the conversion of ETTH to CTTH.

Treatment Procedure

1. PALPATE
Locate the area of pain through palpation and biofeedback.

2. MARK
Mark the area of pain.

3. APPLY GEL
Apply coupling gel to transmit shock waves to the tissue.

4. APPLY SHOCK WAVES
Deliver Radial or Focused Shock Waves to the area of pain while keeping the applicator firmly in place on the skin.

 

Recommended Settings

Swiss
DolorClast }

  Treatment
Number of treatment sessions 3 to 5
Interval between two sessions 1 week
Air pressure Evo Blue® 2.5 to 4 bar
Air pressure Power+ 2 to 4 bar
Impulses 500 - 1000 impulses per trigger point
Frequency 12Hz
Applicator 15mm or 15mm trigger
Skin pressure Light to moderate

Clinical Proof

Bauermeister W.
Stosswellentherapie beim idiopathischen Rückenschmerz pseudoradikulären Syndromen. In: Maier m, Gillesberger F: Abstract 2003 zur Muskuloskelettalen Stosswellentherapie: Norderstedt, 2003, 29-34
http://www.abebooks.fr/9783833004230/Abstracts-2003-Muskuloskelettalen-Stosswellentherapie-Gillesberger-3833004231/plp

Risks

Side effects of Radial Shock Wave Therapy (RSWT®) using the Swiss DolorClast®

When performed properly, RSWT® with the Swiss DolorClast® has only minimal risks.
Typical device-related nonserious adverse events are:

  • Pain and discomfort during and after treatment (anesthesia is not necessary)
  • Reddening of the skin
  • Petechia
  • Swelling and numbness of the skin over the treatment area

These device-related nonserious adverse events usually disappear within 36h after the treatment.

Accordingly the following contraindications of RSWT using the Swiss DolorClast® must be considered:

  • Treatment over air-filled tissue (lung, gut)
  • Treatment of pre-ruptured tendons
  • Treatment of pregnant women
  • Treatment of patients under the age of 18 years (except for Osgood-Schlatter disease and muscular dysfunction in children with spastic movement disorders)
  • Treatment of patients with blood-clotting disorders (including local thrombosis)
  • Treatment of patients treated with oral anticoagulations
  • Treatment of tissue with local tumors or local bacterial and/or viral infections
  • Treatment of patients treated with cortisone.

Stay tuned with the DolorClast

DolorClast
Application }

Learn and improve your knowledge
of the treatment.

> Available on Apple

> Available on Android